Status:
COMPLETED
Fecal Calprotectin in Cystic Fibrosis
Lead Sponsor:
Medical College of Wisconsin
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
1+ years
Brief Summary
Elevated fecal calprotectin is a biomarker for intestinal inflammation in cystic fibrosis
Eligibility Criteria
Inclusion
- All patients
Exclusion
- Informed consent/assent not obtained
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00863694
Start Date
February 1 2009
End Date
August 1 2013
Last Update
December 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States, 53226